dc.contributor.author | Clay-Gilmour, A | |
dc.contributor.author | Chattopadhyay, S | |
dc.contributor.author | Hildebrandt, MAT | |
dc.contributor.author | Thomsen, H | |
dc.contributor.author | Weinhold, N | |
dc.contributor.author | Vodicka, P | |
dc.contributor.author | Vodickova, L | |
dc.contributor.author | Hoffmann, P | |
dc.contributor.author | Nöthen, MM | |
dc.contributor.author | Jöckel, K-H | |
dc.contributor.author | Schmidt, B | |
dc.contributor.author | Langer, C | |
dc.contributor.author | Hajek, R | |
dc.contributor.author | Hallmans, G | |
dc.contributor.author | Pettersson-Kymmer, U | |
dc.contributor.author | Ohlsson, C | |
dc.contributor.author | Späth, F | |
dc.contributor.author | Houlston, R | |
dc.contributor.author | Goldschmidt, H | |
dc.contributor.author | Manasanch, EE | |
dc.contributor.author | Norman, A | |
dc.contributor.author | Kumar, S | |
dc.contributor.author | Rajkumar, SV | |
dc.contributor.author | Slager, S | |
dc.contributor.author | Försti, A | |
dc.contributor.author | Vachon, CM | |
dc.contributor.author | Hemminki, K | |
dc.coverage.spatial | United States | |
dc.date.accessioned | 2022-06-24T09:20:00Z | |
dc.date.available | 2022-06-24T09:20:00Z | |
dc.date.issued | 2022-04-13 | |
dc.identifier | ARTN 60 | |
dc.identifier | 10.1038/s41408-022-00658-w | |
dc.identifier.citation | Blood Cancer Journal, 2022, 12 (4), pp. 60 - | |
dc.identifier.issn | 2044-5385 | |
dc.identifier.uri | https://repository.icr.ac.uk/handle/internal/5189 | |
dc.identifier.eissn | 2044-5385 | |
dc.identifier.eissn | 2044-5385 | |
dc.identifier.doi | 10.1038/s41408-022-00658-w | |
dc.format | Electronic | |
dc.format.extent | 60 - | |
dc.language | eng | |
dc.language.iso | eng | |
dc.publisher | SPRINGERNATURE | |
dc.relation.ispartof | Blood Cancer Journal | |
dc.rights.uri | http://creativecommons.org/licenses/by/4.0/ | |
dc.subject | Humans | |
dc.subject | Monoclonal Gammopathy of Undetermined Significance | |
dc.subject | Paraproteinemias | |
dc.title | Genome-wide meta-analysis of monoclonal gammopathy of undetermined significance (MGUS) identifies risk loci impacting IRF-6. | |
dc.type | Journal Article | |
dcterms.dateAccepted | 2022-01-06 | |
dc.date.updated | 2022-06-24T09:19:26Z | |
rioxxterms.version | VoR | |
rioxxterms.versionofrecord | 10.1038/s41408-022-00658-w | |
rioxxterms.licenseref.startdate | 2022-04-13 | |
rioxxterms.type | Journal Article/Review | |
pubs.author-url | https://www.ncbi.nlm.nih.gov/pubmed/35418122 | |
pubs.issue | 4 | |
pubs.organisational-group | /ICR | |
pubs.organisational-group | /ICR/Primary Group | |
pubs.organisational-group | /ICR/Primary Group/ICR Divisions | |
pubs.organisational-group | /ICR/Primary Group/ICR Divisions/Genetics and Epidemiology | |
pubs.organisational-group | /ICR/Primary Group/ICR Divisions/Genetics and Epidemiology/Cancer Genomics | |
pubs.publication-status | Published online | |
pubs.volume | 12 | |
icr.researchteam | Cancer Genomics | |
dc.contributor.icrauthor | Houlston, Richard | |